1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. APELLIS PHARMACEUTICALS INC
Apellis Pharmaceuticals Inc XNAS: APLS

Apellis Pharma Inc Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement s...

Read More
27.30 1.04 (3.96%)
69.57% Gain from 52W Low
4.0M
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Apellis Pharma Inc is on 12 Jan 2026 for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
34.7 / 100
Momentum Score
Technically Moderately Bullish
68.7 / 100
Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM
Analyst Price Target
35
1Yr Price target upside is 28%
18 analysts

21

S

8

W

2

O

1

T

SWOT Analysis

Apellis Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..